The Influence of the BAD Apoptosis Pathway on Breast Cancer Progression and Relapse-Free Survival after Adjuvant Treatment

被引：0
|
作者：
Ismail-Khan, R. R.
Marichion, D. C.
Xiong, Y.
Fulp, W. J.
Kamath, S. G.
Eschrich, S. A.
Chen, D-T
Lancaster, J. M.
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P3-08-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-08-01
引用
收藏
页数：1
相关论文
共 50 条
  • [31] RELAPSE-FREE SURVIVAL IN BREAST-CANCER PATIENTS - THE IMPORTANCE OF THE PRESENCE OF PROGESTERONE RECEPTORS FOR PROGNOSIS
    ZIELINSKI, CC
    KUZMITS, R
    SPONA, J
    SALZER, H
    KUBISTA, E
    STAFFEN, A
    AIGINGER, P
    BLUT, 1984, 49 (03): : 243 - 243
  • [32] LGR5 overexpression confers poor relapse-free survival in breast cancer patients
    Ming-Feng Hou
    Po-Ming Chen
    Pei-Yi Chu
    BMC Cancer, 18
  • [33] Computational metabolism modeling predicts risk of distant relapse-free survival in breast cancer patients
    Trilla-Fuertes, Lucia
    Gamez-Pozo, Angelo
    Diaz-Almiron, Mariana
    Prado-Vazquez, Guillermo
    Zapater-Moros, Andrea
    Lopez-Vacas, Rocio
    Nanni, Paolo
    Zamora, Pilar
    Espinosa, Enrique
    Fresno Vara, Juan Angel
    FUTURE ONCOLOGY, 2019, 15 (30) : 3483 - 3490
  • [34] Hormones as indicator of relapse-free period in breast cancer (BC).
    Samaneva, Natalia Yu
    Frantsiyants, Elena M.
    Vladimirova, Liubov Yu
    Storozhakova, Anna E.
    Sheiko, Elena A.
    Bandovkina, Valeria A.
    Cheryarina, Natalia D.
    Tikhanovskaya, Natalia M.
    Kit, Oleg, I
    Lisutin, Aleksandr E.
    Shatova, Iuliana S.
    Vashchenko, Larisa N.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] Worse event-free and relapse-free survival in financially disadvantaged patients with breast cancer in South India
    Thumsi, J.
    Nataraj, M.
    Kavitha, M. L.
    Jadhav, S.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S80 - S81
  • [36] Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
    Doherty, AP
    Bower, M
    Smith, GL
    Miano, R
    Mannion, EM
    Mitchell, H
    Christmas, TJ
    BRITISH JOURNAL OF CANCER, 2000, 83 (11) : 1432 - 1436
  • [37] Black race is associated with worse distant relapse-free survival in breast cancer patients treated with neoadjuvant compared to adjuvant systemic chemotherapy.
    Pastoriza, Jessica M.
    Karagiannis, George S.
    Xue, Xiaonan
    Lin, Juan
    Condeelis, John S.
    Sparano, Joseph A.
    Rohan, Thomas E.
    Oktay, Maja H.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 102 - 103
  • [38] Adjuvant immunostimulatory therapy by magnetofection prolonged relapse-free survival for fibrosarcoma bearing cats
    Schillinger, Ulrike
    Rutz, Miriam
    Fischer, Cornelia
    Jahnke, Anika
    Walsch, Florian
    Ferizi, Mehrije
    Benda, Veronika
    Schwarz, Bianca
    Kempf, Tina
    Hirschberger, Johannes
    Koestlin, Roberto
    Brill, Thomas
    Gaensbacher, Bernd
    Plank, Christian
    HUMAN GENE THERAPY, 2009, 20 (11) : 1384 - 1384
  • [39] Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
    A P Doherty
    M Bower
    G L Smith
    R Miano
    E M Mannion
    H Mitchell
    T J Christmas
    British Journal of Cancer, 2000, 83 : 1432 - 1436
  • [40] Changes of topoisomerase IIα expression in breast tumors after neoadjuvant chemotherapy predicts relapse-free survival
    Tinari, N
    Lattanzio, R
    Natoli, C
    Cianchetti, E
    Angelucci, D
    Ricevuto, E
    Ficorella, C
    Marchetti, P
    Alberti, S
    Piantelli, M
    Iacobelli, S
    CLINICAL CANCER RESEARCH, 2006, 12 (05) : 1501 - 1506
12345